Proton Therapy: An Emerging Treatment Modality for Common Malignancies - 2009

This article has been archived.
Please use for reference only.

The Abramson Cancer Center of the University of Pennsylvania
Last Modified: November 17, 2009

Share article


OncoLink TV

On Tuesday evening, November 3, 2009, the University of Florida Proton Therapy Institute, Massachusetts General Hospital - Burr Proton Therapy Center and the University of Texas MD Anderson Cancer Center conducted an educational symposium at the Hyatt Regency McCormick Place in Chicago, Illinois. Nearly 500 attended "Proton Therapy: An Emerging Treatment Modality for Common Malignancies," supported by an educational grant from IBA.

Launch Webcast


News
ASTRO: Combination Therapy Beneficial in Prostate Cancer

Aug 30, 2014 - Long-term survival may be increased in medium-risk prostate cancer patients who receive short-term androgen deprivation therapy before and during radiation treatment compared with men who receive radiation alone. In addition, proton beam therapy may be associated with a decreased risk of disease recurrence after 10 years and has minimal side effects after one year, according to research presented at the 51st Annual Meeting of the American Society for Radiation Oncology, held from Nov. 1 to 5 in Chicago.



OncoLink Treatment Binder

Select the side effects and forms for your patient's treatment binder

Learn More



Blogs and Web Chats

OncoLink Blogs give our readers a chance to react to and comment on key cancer news topics and provides a forum for OncoLink Experts and readers to share opinions and learn from each other.




OncoLink OncoPilot

Facing a new cancer diagnosis or changing the course of your current treatment? Let our cancer nurses help you through!

Learn More